The Lithuanian competition authority conducted a market study on the parallel import of pharmaceuticals. The aim of the study was to assess the situation in the Lithuanian pharmaceutical market and identify the main circumstances determining a low share of the trade of parallel imported pharmaceuticals in Lithuania, as well as to provide proposals on how effective competition could be ensured in the market.